Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 9-aminomethyl minocycline compounds and use thereof in treating community-acquired bacterial pneumonia (CABP)

9-aminomethyl minocycline compounds and use thereof in treating community-acquired bacterial pneumonia (CABP)

US Patent 10835542 · Granted Nov 17, 2020

Estimated economic value: $5,235,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating mycobacterial infections using tetracycline compounds2024
Minocycline compounds for biodefense2021
9-aminomethyl minocycline compounds and use thereof in treating community-acquir2019
9-aminomethyl minocycline compounds and use thereof in treating community-acquir2019
9-aminomethyl minocycline compounds and use thereof in treating community-acquir2019
9-aminomethyl minocycline compounds and use thereof in treating community-acquir2019
9-aminomethyl minocycline compounds and use thereof in treating community-acquir2019
9-aminomethyl minocycline compounds and methods of use thereof in urinary tract 2019
9-aminomethyl minocycline compounds and methods of use thereof in urinary tract 2019
9-aminomethyl minocycline compounds and methods of use thereof in urinary tract 2019
9-aminomethyl minocycline compounds and methods of use thereof in urinary tract 2019
Minocycline compounds and methods of use thereof2018